cFMS kinase inhibitor (Redx Oncology)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamecFMS kinase inhibitor (Redx Oncology)
Drug Alias NamecFMS kinase inhibitors (oral, autoimmune diseases/inflammation/cancer) (Redx)small molecule FMS kinase inhibitors (Aegera)cFMS kinase inhibitor (Redx Pharma)CSF-1R kinase inhibitors (Aegera)small molecule cFMS kinase inhibitors (Redx) +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophage Colony Stimulating Factor 1 inhibitors
TargetsMacrophage Colony Stimulating Factor 1
Therapy Area/IndicationsFractures, BoneInflammationAutoimmune Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAegera Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRedx Oncology LtdRedx Pharma PlcAegera Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsFractures, BoneInflammationAutoimmune Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A